Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
It makes and sells vitamins, supplements, and over-the-counter medicines that people take to stay healthy or treat everyday ailments.
Procter & Gamble Health is a medicines and supplements company in India. It sells the kind of products you'd find in a pharmacy or a supermarket health aisle: daily multivitamins, iron and calcium tablets, cough and cold remedies, and skin ointments. Its best-known brands include Neurobion, a vitamin B supplement, and Livogen, an iron supplement. These aren't prescription drugs for serious illness. They're everyday health products that people buy on their own, often again and again.
The company is a rare animal in the Indian pharma world. It isn't an independent business that grew from scratch. It's the Indian arm of the global consumer giant Procter & Gamble, which means the health business sits inside a company better known for shampoo and detergent. For years this Indian unit was actually part of Merck, the German drug and science company, before P&G bought the consumer health piece and eventually folded it into its own Indian health business. That history matters because it explains the brand portfolio: these are old, trusted pharmacy names that have been on Indian shelves for decades, not new inventions. The business works on a simple engine: build brand trust, then let repeat purchases do the work. When your grandmother used Neurobion and your doctor recommends Livogen, you don't spend much time comparison shopping. That trust gives the company pricing power and steady demand, though it competes hard with other vitamin makers and cheaper generic supplements. It also spends heavily on advertising and on salespeople who visit doctors and pharmacies to keep the brands top of mind, which nibbles into the fat-looking margins that supplements can earn.
One thing worth knowing: the company is small relative to its parent's empire, and its fortunes are tied to a very Indian habit of self-medicating with vitamins and tonics. That's a large, growing market as incomes rise and people get more health-conscious, but it's also crowded and price-sensitive. The company leans on its parent's global brands and marketing muscle, pays out much of its profit as dividends to shareholders, and isn't trying to be a research-driven drugmaker. It's a brand-and-distribution business dressed up as a health company.
Saved answer 路 last researched 16 Nov 2026